Synaptogenix Financial Statements From 2010 to 2025

SNPX Stock  USD 2.70  0.09  3.23%   
Synaptogenix financial statements provide useful quarterly and yearly information to potential Synaptogenix investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Synaptogenix financial statements helps investors assess Synaptogenix's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Synaptogenix's valuation are summarized below:
Market Capitalization
4.1 M
Earnings Share
10.27
We have found one hundred seventeen available fundamental trend indicators for Synaptogenix, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of Synaptogenix current market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road.
Check Synaptogenix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Synaptogenix's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 1.8 M or Interest Income of 1.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.19 or PTB Ratio of 0.14. Synaptogenix financial statements analysis is a perfect complement when working with Synaptogenix Valuation or Volatility modules.
  
Check out the analysis of Synaptogenix Correlation against competitors.
For more information on how to buy Synaptogenix Stock please use our How to Invest in Synaptogenix guide.

Synaptogenix Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets28.6 M35.8 M22.2 M
Slightly volatile
Other Current Liabilities4.6 M4.4 M951.8 K
Slightly volatile
Total Current Liabilities5.2 M4.9 M1.5 M
Slightly volatile
Total Stockholder Equity25.8 M29.4 M20.6 M
Slightly volatile
Net Tangible Assets24.4 M37.6 M21.3 M
Slightly volatile
Property Plant And Equipment Net16.8 K16.7 K20.8 K
Slightly volatile
Accounts Payable652 K400.2 K552.8 K
Slightly volatile
Cash27.2 M33 M21.3 M
Slightly volatile
Non Current Assets Total701.4 K668 K139.5 K
Slightly volatile
Cash And Short Term Investments27.5 M34.6 M21.5 M
Slightly volatile
Common Stock Shares Outstanding398.5 K419.5 K4.6 M
Slightly volatile
Liabilities And Stockholders Equity28.6 M35.8 M22.2 M
Slightly volatile
Non Current Liabilities Total1.3 M1.4 M787.8 K
Slightly volatile
Other Current Assets908.7 K497.7 K624 K
Slightly volatile
Other Stockholder Equity43.4 M52.2 M82.7 M
Slightly volatile
Total Liabilities6.7 M6.4 M1.9 M
Slightly volatile
Net Invested Capital24.9 M28 M20.2 M
Slightly volatile
Property Plant And Equipment Gross24.1 K25.5 K22.2 K
Slightly volatile
Total Current Assets28.4 M35.1 M22.1 M
Slightly volatile
Net Working Capital26.3 M30.2 M20.8 M
Slightly volatile
Common Stock2.9 K2.8 K1.4 K
Slightly volatile
Property Plant Equipment17.3 K19.9 K21.3 K
Slightly volatile
Net Receivables102 K114.7 K125.1 K
Slightly volatile
Other Liabilities3.7 M4.1 M4.5 M
Slightly volatile
Other Assets0.80.90.9813
Slightly volatile

Synaptogenix Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Interest Income1.8 M1.7 M586.3 K
Slightly volatile
Interest Income1.8 M1.7 M586.3 K
Slightly volatile
Depreciation And Amortization5.8 K7.3 K4.9 K
Slightly volatile
Interest Expense25 M23.8 M5.9 M
Slightly volatile
Selling General Administrative6.8 M5.7 MM
Slightly volatile
Other Operating Expenses10.2 M7.5 M13.8 M
Slightly volatile
Research Development3.4 M1.8 M4.9 M
Slightly volatile
Cost Of Revenue5.8 K7.3 K4.9 K
Slightly volatile
Total Operating Expenses10.2 M7.5 M13.8 M
Slightly volatile
Reconciled Depreciation5.9 K7.7 KK
Slightly volatile
Selling And Marketing Expenses5.1 K5.7 K6.2 K
Slightly volatile

Synaptogenix Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation863 K908.4 K3.3 M
Slightly volatile
Begin Period Cash Flow27.2 M43.1 M28.4 M
Very volatile
Depreciation5.8 K7.3 K4.9 K
Slightly volatile
Capital Expenditures3.8 K2.4 K4.8 K
Slightly volatile
End Period Cash Flow27.2 M33 M21.3 M
Slightly volatile
Change To Inventory102 K114.7 K125.1 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Dividend Yield0.190.180.1087
Pretty Stable
PTB Ratio0.140.12396.9354
Pretty Stable
Book Value Per Share33.9563.1373.3777
Slightly volatile
Average PayablesM635.3 K1.1 M
Slightly volatile
Capex To Depreciation0.470.490.9493
Slightly volatile
PB Ratio0.140.12396.9354
Pretty Stable
Payables Turnover0.01350.01280.0048
Slightly volatile
Cash Per Share37.6974.2780.4884
Slightly volatile
Days Payables Outstanding27.9 K29.4 K220.3 K
Slightly volatile
Income Quality0.760.770.7998
Slightly volatile
Net Debt To EBITDA1.73.112.4065
Pretty Stable
Current Ratio7.88.2112.5927
Pretty Stable
Tangible Book Value Per Share33.9563.1373.3777
Slightly volatile
Graham Number99.24145220
Slightly volatile
Shareholders Equity Per Share33.9563.1373.3777
Slightly volatile
Capex Per Share0.00480.00670.009
Slightly volatile
Graham Net Net32.8560.6371.4664
Slightly volatile
Average Receivables51 K57.4 K62.5 K
Slightly volatile
Price Book Value Ratio0.140.12396.9354
Pretty Stable
Days Of Payables Outstanding27.9 K29.4 K220.3 K
Slightly volatile
Ebt Per Ebit0.960.840.9346
Slightly volatile
Company Equity Multiplier0.911.091.1069
Pretty Stable
Quick Ratio7.88.2112.5927
Pretty Stable
Net Income Per E B T1.121.131.005
Slightly volatile
Cash Ratio7.327.7112.1955
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.80.90.9816
Slightly volatile
Price To Book Ratio0.140.12396.9354
Pretty Stable
Price Fair Value0.140.12396.9354
Pretty Stable

Synaptogenix Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.5 M2.9 M3.1 M
Slightly volatile

Synaptogenix Fundamental Market Drivers

Cash And Short Term Investments30.1 M

Synaptogenix Upcoming Events

19th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Synaptogenix Financial Statements

Synaptogenix investors use historical fundamental indicators, such as Synaptogenix's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Synaptogenix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue7.3 K5.8 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Synaptogenix Stock Analysis

When running Synaptogenix's price analysis, check to measure Synaptogenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synaptogenix is operating at the current time. Most of Synaptogenix's value examination focuses on studying past and present price action to predict the probability of Synaptogenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synaptogenix's price. Additionally, you may evaluate how the addition of Synaptogenix to your portfolios can decrease your overall portfolio volatility.